Introduction {#sec1}
============

Angiogenesis involves the assembly of angioblasts, vessel sprouting, and pericyte conscripting, as well as the formation of branches, tubes, and capillaries by the endothelial smooth muscle cells from the current vessel network.^[@ref1]−[@ref4]^ The vascular network formed by the proangiogenic factors functions in the transportation of oxygen and nutrients to various tissues where they are required for growth and proper development. Angiogenesis is controlled by the balance between anti- or proangiogenic activity, resulting from soluble and membrane-bound factors, including neutrophils, stem cell factors, semaphorins, ephrins, matrix metalloproteinase, endostatin, proteases, cytokines, and chemokines. Uncontrolled angiogenesis has been implicated in pathophysiological conditions including cancer, inflammation, diabetes, and neurodegeneration.^[@ref5]−[@ref7]^

Numerous stages of sprout extension and vessel maturation have been studied extensively; however, the exact molecular mechanisms that initiate the angiogenic reactions remain elusive.^[@ref2],[@ref8]−[@ref13]^ Previously, we demonstrated that natural products containing a conjugated double bond, including anthocyanin extracts from *Hibiscus sabdariffa*, may control proper angiogenesis.^[@ref14]^ The results provided evidence that anthocyanin is an antiangiogenic modulator that can be used to treat uncontrolled neovascular-related diseases, possibly binding to vascular endothelial growth factor receptor 2 (VEGFR2).

In this study, we hypothesized that specific natural molecules present in chick embryo are implicated in angiogenic initiation, either to upregulate or downregulate the process. To test the hypothesis, we examined the natural molecules as a promoter or inhibitor using chick chorioallantoic membrane (CAM) models with an unbiased metabolomics approach by gas chromatography--mass spectrometry (GCMS) and vessel morphology analysis. Our experiments demonstrated that oleic acid, linoleic acid, and cholesterol could be involved in the initial step of vessel formation.

Results and Discussion {#sec2}
======================

White Lipid Complex as the Angiogenesis Initiators {#sec2.1}
--------------------------------------------------

When a fertilized chick embryo is incubated, the first sign was observed that a white lipid complex area was formed as the angiogenesis initiation signature ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref15]^ The white streak or circular area was analyzed further in chick embryo incubation day 1 (ED = 1). The white lipid complex was collected from 8, 16, and 24 h for kinetic analysis, and time-dependent changes were observed. The white area becomes evident by time (8, 16, and 24 h), and the area becomes smaller and distinct. Pixels of each area were analyzed using 3D analysis in ImageJ software.

![White lipid complex area as the angiogenesis initiation signature. The white streak or circular area was observed in chick embryo incubation day 1 (ED = 1). The white area was expanded for analysis for 8, 16, and 24 h, and pixels of each area were analyzed using the 3D tool in ImageJ software.](ao0c02850_0001){#fig1}

Next, we examined the metabolome of the chicken embryo on day 1 (ED 1). After 24 h of incubation, the white rounded section was distinguished, as shown by the arrow ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). Molecules in two distinct areas of A and B were extracted using a solvent mixture consisting of chloroform, methanol, and water (or phosphate-buffered saline, PBS). The hydrophobic molecules extracted using the organic solvent were analyzed by GCMS.

![Unbiased metabolomics analysis of chicken embryo on day 1 (ED 1). After 24 h of incubation, the white rounded section was distinguished, as shown by the arrow. Organic molecules were extracted from two distinct areas of A and B using chloroform, methanol, and PBS. The hydrophobic molecules from areas A and B were analyzed by GCMS.](ao0c02850_0002){#fig2}

To compare the white lipid complex with the vessel area, we further examined the metabolome of the chicken embryo at day 7 (ED 7). After 7 days of incubation, blood vessel formation was distinguished, as shown by area A ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). Three distinct areas of A (vessel area), B (vessel starting point), and C (nonvessel area) were extracted using a solvent mixture (chloroform, methanol, and PBS). The hydrophobic molecules were analyzed by GCMS and compared to molecules from day 1.^[@ref16]−[@ref18]^

![Unbiased metabolomics analysis of chicken embryo at day 7 (ED 7). After 7 days of incubation, blood vessel formation was distinguished, as shown by area A. Organic molecules were extracted from three distinct areas of A (vessel area), B (vessel starting area), and C (nonvessel area) and were extracted using chloroform, methanol, and PBS. The hydrophobic molecules from areas A, B, and C were analyzed by GCMS.](ao0c02850_0003){#fig3}

GCMS Analysis of Angiogenic Molecules {#sec2.2}
-------------------------------------

The unknown molecules from [Figures [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"} were analyzed using GCMS ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). We observed two distinct peaks at 22 and 25 min from the white area ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}A), indicating two molecules of the highest concentrations (10--12-fold) at embryonic day 1 in the vessel area. Unknown molecules in the nonvessel area at embryonic day 1 were also analyzed by GCMS. The result shows that 12 molecules exist between 8 and 30 min of retention time ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}).

![GCMS chromatogram of the vessel area at chick embryonic day 1. One gram of white area was collected and extracted using an organic solvent mixture. Molecules in the white area were analyzed using GCMS to identify molecular weight and fragmentation patterns. Two distinct peaks at 22 and 25 min were further analyzed for the second mass spectrum for *m*/*z* values for the molecular ion peak (M^+^) and the tallest base peak. The *X*-axis represents retention time (minutes), and the *Y*-axis shows relative abundance.](ao0c02850_0004){#fig4}

![GCMS chromatogram of the nonvessel area at chick embryo day 1. One gram of the white area was collected and extracted using an organic solvent mixture. Molecules in the nonvessel area were analyzed using GCMS to identify molecular weight and fragmentation patterns. Twelve peaks between 5 and 30 min were further analyzed for the second mass spectrum for *m*/*z* values. The *X*-axis represents retention time (minutes), and the *Y*-axis shows relative abundance.](ao0c02850_0005){#fig5}

The two distinct peaks at 22 and 25 min in the white area, as the angiogenesis initiation signature, were further analyzed by the mass to charge ratio (*m*/*z*) and relative abundance ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}). The fragmentation pattern of the major peaks at 22 min is assigned as follows: C~3~ = 71, C~4~ = 86, C~7~^′^ = 97, C~7~ = 129, C~19~--CH~3~OH = 264, and the molecular ion peak M^+^ = 282 ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}A).

![GCMS analysis of the vessel area at 22 min. (A) Molecules in the white circular area at 22 min were analyzed by their molecular weight and fragmentation pattern. The fragmentation pattern of the major peaks is assigned as follows: C~3~ = 71, C~4~ = 86, C~7~^′^ = 97, C~7~ = 129, and molecular ion M^+^ (C~18~) = 282. (B) Database search identified the unknown molecule as oleic acid, as the positive control. *m*/*z* values of all fragments were compared to an authentic sample of oleic acid (not shown) and the known spectrum of oleic acid from the database.](ao0c02850_0006){#fig6}

The major peaks with *m*/*z* and the relative abundance at 22 min were identified by the database search as oleic acid compared to the positive control ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}B). *m*/z values of all fragments were compared to the authentic sample of oleic acid and the known spectrum of oleic acid from the database.^[@ref19]−[@ref22]^

The next major peak at 25 min in the vessel area was identified as cholesterol using GCMS analysis ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}). The major peaks are fragments of cholesterol that include C~4~ = 55, C~7~ = 97, C~11~ = 145, C~16~ = 231, 241, C~19~ = 275, M^+^--OH = 369, and the molecular ion as M^+^ (C~27~) = 386 ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}A). The identity of the major angiogenic molecule was validated by the comparison to the positive control ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}B). *m*/*z* values of all fragments were compared to the authentic sample of cholesterol and the known spectrum of cholesterol from the database.^[@ref23],[@ref24]^

![GCMS analysis of the vessel area at 25 min. (A) Molecules in the white circular area at 25 min were analyzed by their molecular weight and fragmentation pattern. Fragmentation pattern of the major peaks are assigned as follows: C~4~ = 55, C~7~ = 97, C~11~ = 145, C~16~ = 231, 241, C~19~ = 275, M + −OH = 369, and molecular ion as M^+^ (C~27~) = 386. (B) Database search identified the unknown molecule as cholesterol, as a positive control. *m*/*z* values of all fragments were compared to an authentic sample of cholesterol (not shown) and the known spectrum of cholesterol from the database.](ao0c02850_0007){#fig7}

Interestingly, we observed one more molecule at the 25 min peak from the vessel area, and GCMS analysis demonstrated it as linoleic acid ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}). The major peaks include C~4~^′^ = 55, C~3~ = 72, C~4~ = 87, C~7~^′^ = 94, C~7~^′^ = 97, C~7~ = 135, C~11~^′^ = 150, M^+^--CO~2~ = 236, and the molecular ion peak M^+^ = 280 ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}A). The database search identified the unknown molecule as linoleic acid compared to the positive control ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}B). *m*/*z* values of all fragments were compared to the known spectrum of linoleic acid from the database.^[@ref20],[@ref25]−[@ref27]^ GCMS analysis of the vessel area from [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"} also demonstrated that oleic acid, linoleic acid, and cholesterol are the major angiogenesis signature molecules.

![GCMS analysis of the vessel area at 25 min. (A) Molecules in the white circular area at 25 min were analyzed by their molecular weight and fragmentation pattern. The fragmentation pattern of the major peaks is assigned as follows: C~4~^′^ = 55, C~3~ = 72, C~4~ = 87, C~7~^′^ = 94, C~7~^′^ = 97, C~7~ = 135, C~11~^′^ = 150, M^+^--CO~2~ = 236, and molecular ion peak M^+^ = 280. (B) Database search identified the unknown molecule as linoleic acid, shown as a positive control. *m*/*z* values of all fragments were compared to an authentic sample of linoleic acid and the known spectrum of linoleic acid from the database.](ao0c02850_0008){#fig8}

Next, we examined potential angiogenic molecules using a gain-of-function approach by the addition of cholesterol and oleic acid into the chick embryo. Accelerated vessel formation was observed by the injection of cholesterol+ (55 mg) and cholesterol++ (110 mg) in a dose-dependent manner, compared to the negative control (solvent only) ([Figure [9](#fig9){ref-type="fig"}](#fig9){ref-type="fig"}). Cholesterol was injected on the CAM after preincubation day 2, and vessel formation was analyzed postinjection of cholesterol day 1.

![Cholesterol addition experiment. The gain-of-function study was conducted by the addition of cholesterol+ (55 mg), cholesterol++ (110 mg), and the control (solvent only). Cholesterol was added after preincubation, day 2, and chick embryo was analyzed postinjection of cholesterol, day 1. Scale bar = 10 mm.](ao0c02850_0009){#fig9}

The kinetic study for gain of function was conducted by the injection of cholesterol at different concentrations and examined at various time points. Two optimized concentrations of cholesterol (55 and 110 mg) were injected after preincubation day 2, and chick embryo was analyzed postinjection of cholesterol day 4, showing time-dependent vessel growth after the addition of cholesterol ([Figure [10](#fig10){ref-type="fig"}](#fig10){ref-type="fig"}). However, postinjection of cholesterol day 1 showed the more drastic changes in vessel growth than postinjection of cholesterol day 4, indicating that the effect of cholesterol on angiogenesis is significant (*p* \< 0.001) at an early time point. The injection of oleic acid showed a similar pattern of vessel growth as cholesterol addition ([Figure [11](#fig11){ref-type="fig"}](#fig11){ref-type="fig"}).

![Cholesterol addition experiment. The gain-of-function study was conducted by the addition of cholesterol+ (55 mg), cholesterol++ (110 mg), and the control (solvent only). Cholesterol was added after preincubation, day 2, and chick embryo was analyzed postinjection of cholesterol, day 4. Scale bar = 10 mm.](ao0c02850_0010){#fig10}

![Cholesterol or oleic acid addition experiment. Gain-of-function study was conducted by the addition of cholesterol+ (55 mg), cholesterol++ (110 mg), oleic acid + (45 mg), and oleic acid ++ (200 mg) compared to the negative control (solvent only). Cholesterol or oleic acid were added after preincubation, day 2, and chick embryo was analyzed postinjection, day 4. Vessel morphology was further analyzed using bioinformatics tools including Angiogenesis Analyzer. Scale bar = 5 mm.](ao0c02850_0011){#fig11}

Time-dependent and dose-dependent vessel growth were analyzed quantitatively using bioinformatics tools, including Angiogenesis Analyzer and AutoTube. To determine the angiogenic morphology systematically, we measured 21 angiogenic indices using Angiogenic Analyzer macro (Gilles Carpentier, <http://image.bio.methods.free.fr/ImageJ/Angiogenesis-Analyzer-for-ImageJ>) on cholesterol-treated versus control chick embryos (CAM). The Angiogenic Analyzer detects vessel networks and analyzes the vascular organization of endothelial cells. To evaluate the proangiogenic effects of oleic acid, cholesterol, and linoleic acid, the Analyzer obtains a quantitative evaluation of the vessel network by extracting characteristic information of the angiogenic images. Cholesterol/oleic acid-treated samples were analyzed using the raw image and the edge/inverted image ([Figure [11](#fig11){ref-type="fig"}](#fig11){ref-type="fig"}).

We determined the angiogenic parameters, including extremities, nodes, junctions, master junction, master segments, master segment length, meshes, total mesh area, number of segments, isolated elements and branches, number of segments, branches, number of isolated elements, total length, total branch length, total segment length, total branch length, total isolated branch length, branching interval, total segment length/branches, mesh index, master segment length/master segments, and mean mesh size ([Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02850/suppl_file/ao0c02850_si_001.pdf), Figures S1--S5, Table S1). Quantitative analysis revealed that cholesterol++ (110 mg) generated longer vessels and more branches compared to the control and less cholesterol+ (55 mg) addition (*p* \< 0.001) ([Figure [12](#fig12){ref-type="fig"}](#fig12){ref-type="fig"}). GCMS analysis showed that specific lipids increased to generate the white circle area just before massive angiogenic reactions, implying that the hydrophobic microenvironment might be required for the initial vessel growth.

![Angiogenic analysis by bioinformatics tools. Vessel morphology, including vessel length and branches, was analyzed quantitatively using the angiogenic index. The vessel length is longer in cholesterol+ (twofold) and cholesterol++ (sixfold) compared to the negative control (vehicle only) at preincubation, day 2 and postinjection, day 1.](ao0c02850_0012){#fig12}

Abnormal vessel formations accelerate the progression of specific angiogenic diseases in the retina including diabetic retinopathy (DR) and age-related macular degeneration (AMD).^[@ref28]−[@ref35]^ Adequate vessel growth and maintenance represent the coordinated process of endothelial cell proliferation, matrix remodeling, and differentiation. Uncontrolled angiogenic reactions are the major pathological components of the late stage of wet AMD when abnormal blood vessels are developed in the macula.^[@ref36]^

The chick embryo model is a powerful tool to analyze the angiogenic factors, including proteins, small molecules, and cells.^[@ref37]−[@ref42]^ The CAM is an indicator of vessel morphology, containing highly vascularized tissues with short kinetics as 21 days of phenotypic time points.^[@ref43]−[@ref47]^

Previously, our proteomic studies under stress conditions identified the molecular changes in the retina and retinal pigment epithelium (RPE). Our data demonstrated that certain lipids were altered, including cardiolipin and cholesterol as specific biomarkers of angiogenesis and apoptosis in the retina and RPE under stress conditions.^[@ref48]^

In addition, we determined the mechanism underlying normal and pathological angiogenesis, regulated by *H. sabdariffa* extracts as natural antiangiogenic molecules, whereas vegetable lipids may accelerate vessel growth. We suggested that anthocyanin from the *Hibiscus* plant may bind to VEGFR2 to inhibit angiogenesis. We compared antiangiogenic anthocyanin to selected fatty acid mixtures as angiogenic stimulators. Fatty acids, including oleic (18:1), linoleic (18:2, w6), linolenic (18:3, w3), palmitic (16:0), and palmitoleic (16:1), upregulated vessel length and branches by 20--50% compared to the negative control.

The current study determines the angiogenesis initiators in the chick embryo using a metabolomics approach including mass spectrometry and vessel morphology analysis. Despite the fact that the angiogenesis-related proteins including VEGF and erythropoietin have been considered as proangiogenic factors, the molecular function of small organic molecules remains elusive. It is a reasonable hypothesis that specific lipids may play certain roles in angiogenesis based on pro- and antiangiogenic reactions including free fatty acids or cholesterol.

Fatty Acids as Angiogenic Stimulators {#sec2.3}
-------------------------------------

Fatty acids are effective proangiogenic factors including eicosanoid that regulates vascular endothelial cell proliferation, migration, and capillary formation.^[@ref49]−[@ref54]^ Free fatty acids induce activation of signal transduction pathways that mediate several biological processes in addition to the role of the energy source of many carbon--carbon bonds.^[@ref55]−[@ref58]^

The current experiments indicate that oleic acid, cholesterol, and linoleic acid may act as potential molecular determinants and initiators of angiogenesis for the proper balance of acceleration and inhibition signaling that controls the vascular microenvironment. The natural angiogenic molecules could be a potential target for the treatment of uncontrolled angiogenic diseases including DR and AMD.

Oleic acid is a C~18~ monounsaturated fatty acid with the double bond at C~9~, activating G protein-coupled receptors including ERK1/2 to induce cancer cell proliferation.^[@ref59],[@ref60]^ Oleic acid exists in normal serum (50 μmol/L), but with a higher concentration (\>0.025 mmol/L), oleic acid may induce tumor cell development.^[@ref61],[@ref62]^ Oleic acid induces proliferation, matrix metalloproteinase-9 (MMP-9) secretion, migration, and invasion.^[@ref63]^

In terms of protein--metabolite interaction, oleic acid induces AKT1 and AKT2 activation and an increase in NFκB-DNA binding activity in cancer cells.^[@ref60],[@ref64]−[@ref66]^ Endothelial cell migration in vessel growth requires oleic acid-specific proteins including FFAR1, FFAR4, EGFR, AKT, and PI3K. Recently, it has been reported that nitro-oleic acid enhances regional angiogenesis in an abdominal wall defect murine model.^[@ref67]−[@ref69]^

Angiogenesis is regulated by cholesterol efflux from endothelial cells to high-density lipoproteins *via* apoA-I binding protein.^[@ref70]^ Higher microvessel density was observed from the high-cholesterol/high-fat diet to conclude that hypercholesterolemia accelerates tumor growth and induces angiogenesis *in vivo*.^[@ref71]−[@ref73]^

Conjugated linoleic acid has controversy as an antiangiogenic or proangiogenic molecule based on the kinetics and dose-dependent mechanisms in the various models.^[@ref74]−[@ref77]^ As an accelerator of angiogenesis, linoleic acid can enhance the plasminogen activator inhibitor 1 (PAI-1) and induce angiogenesis by suppression of angiostatin. Linoleic acid does not alter tumor cell growth *in vitro*; however, dietary linoleic acid upregulates tumor growth *in vivo*.

Linoleic acid upregulates leukotriene B~4~ (LTB~4~), tumor necrosis factor-α (TNF-α), and cytokine-induced neutrophil chemotaxis (CINC-2αβ) and downregulates macrophage inflammatory protein-1 (MIP-1) and macrophage chemoattractant protein-1 (MCP-1).^[@ref78]^ Furthermore, linoleic acid induces angiogenesis through specific mediators including angiopoietin-2 (ANGPT-2) and VEGF. Linoleic acid with the conjugated double bonds may have dual roles as an antiangiogenic, antioxidative molecule (double bond oxidation) and a proangiogenic molecule as a free fatty acid complex for vessel growth and angiogenic protein recruiter under the microenvironment. Our data imply that the initial reactions of angiogenesis may demand specific unsaturated fatty acids and cholesterol for their carbon building block and an energy source.

Conclusions {#sec3}
===========

In this study, we hypothesized that the proangiogenic and antiangiogenic molecules exist as the natural angiogenic determinants, which regulate the development of blood vessel networks. We identified the lipid complex as the angiogenesis signature and vessel growth molecules through a metabolomics approach. Mass spectrometry analysis identified oleic acid, cholesterol, and linoleic acid as natural angiogenesis initiators that control vessel growth in a time-dependent and dose-dependent manner. Quantitative determination of angiogenesis using 21 angiogenic indexes provided the evidence that the uncovered lipids initiate angiogenesis and are a potential drug target for treating uncontrolled angiogenesis-related diseases, including DR and AMD.^[@ref79]−[@ref82]^

Materials and Methods {#sec4}
=====================

*In Vivo* Experiments {#sec4.1}
---------------------

We followed the NIH Guide and the Association for Research in Vision and Ophthalmology (ARVO) statement for *in vivo* experiments. Avian embryos are not considered live animals under the Public Health Service (PHS) policy. The use of chicken embryos at gestation day 12 and younger does not require an Animal Use Protocol Application from the Institutional Animal Care and Use Committee (IACUC). Chick embryos younger than embryonic day 13 (ED13) are assumed unable to experience pain. Therefore, ED13 and younger embryos were euthanized by hypothermia, typically conducted by placing the eggs in a −20 °C freezer or \<4 °C for 4 h. Embryonic death was confirmed by decapitation, membrane disruption, or maceration. Chick embryos between ED13--ED17 can experience pain and were euthanized by cervical dislocation.

Chick Embryo Incubation {#sec4.2}
-----------------------

We used CAM assay to investigate the vascular morphology and angiogenic molecules using metabolomics approaches including mass spectrometry analysis.^[@ref83]−[@ref85]^ Fertilized eggs of white Leghorn chickens were purchased from Veterinary Research Institute Jos and incubated for 1--21 days at 37.5 °C with 62--72% humidity in a laboratory incubator with continuous rotation. Chick embryos were incubated for each day (ED1--ED21) and harvested in Petri dishes.

For lipid addition experiments, both dose-dependent effects and time-dependent vessel growth were examined. Cholesterol (55, 110 mg) or oleic acid (45, 200 mg) in PBS/dimethyl sulfoxide was added after preincubation day 2 using a microsyringe (200 μL capacity, Hamilton Company, Bonaduz, Switzerland) through the hole (0.2 mm diameter) made with forceps. Solvent toxicity was validated by the negative control (vehicle only). After lipid addition, the chick embryo was sealed with 3M transparent scotch tape and further incubated for 1--4 days followed by harvest and vessel analysis.

Lipid Extraction from Chick Embryo {#sec4.3}
----------------------------------

One gram of each sample was collected from the vessel area, vessel beginning area, and nonvessel areas of the chick embryo and extracted using organic solvents (methanol 2 mL, water or PBS 4 mL, and chloroform 8 mL). The mixtures were mixed using a vortex until the solution becomes homogenous. The samples were centrifuged (3500*g* for 5 min). The lower phase was collected into vials and evaporated to dryness at room temperature (27 ± 3 °C), and the samples were subsequently dissolved in hexane and were used for biochemical analysis.^[@ref86],[@ref87]^

GCMS Analysis {#sec4.4}
-------------

GCMS analysis was carried out using an Agilent Technologies gas chromatograph (Agilent 7890A) coupled to a mass spectrometer (Agilent 5975C) and fitted with an autosampler (Agilent 7683B). Samples (0.2 μL) were injected using a split ratio of 1:1 by the autosampler into the inlet. The capillary column (DB-5MS 30 m × 0.322 mm × 0.25 μm) with a temperature limit of 325 °C was used, and temperature programming was initiated at 60 °C for 1 min and continued to increase by 10 °C/min to 280 °C for 21 min, giving rise to a total of 35 min run time. Helium gas of 99.99% purity was used as the carrier gas at a flow rate of 1.1 mL/min at a pressure of 5.154 psi. Finally, the identity of the samples was obtained through the interpretation of the mass spectrum from the database of the National Institute Standard and Technology (NIST 2014 and NIST 2011).

The unknown component of the mass spectrum was compared to the known compounds stored in the database of the instrument. The metabolome database (<http://www.hmdb.ca/spectra/ms/search>) was searched manually for the confirmation of lipids presented by the NIST database, according to their mass to charge ratio, fragmentation pattern, and relative abundance.^[@ref23],[@ref27],[@ref88],[@ref89]^

Angiogenic Analysis of the Chick Embryo CAM {#sec4.5}
-------------------------------------------

Vessel morphology was analyzed quantitatively using 21 angiogenic parameters by bioinformatics tools that include Angiogenesis Analyzer macro connected ImageJ software.^[@ref90]−[@ref94]^ Angiogenesis Analyzer macro was installed in the toolsets (Gilles Carpentier, <http://image.bio.methods.free.fr/ImageJ/Angiogenesis-Analyzer-for-ImageJ>). Each image was converted into a 16-bit image, and HUVEC phase contrast/Fluo images were analyzed to show vessel morphology. Besides, the following software was used for comparison, AutoTube (<https://github.com/autotubularity/autotube>), AngioTool (<http://angiotool.nci.nih.gov>), REAVER (<https://github.com/bacorliss/public_REAVER>), VESSGEN 2D (<https://software.nasa.gov/software/ARC-17621-1>), and Vessel Analysis (<https://imagej.net/Vessel_Analysis>). The angiogenic analysis showed changes in vessel morphology including vessel length, branches, and extremities; nodes were identified as three neighbors; twig, segment delimited by two junctions and a branch. A junction is implicated only in-branch, and master junctions are delimiting master segments. The master tree is composed of master segments associated with master junctions delimiting the meshes. Two close master junctions can be fused into a unique master junction and the underlying segment.

Statistical Analysis {#sec5}
====================

Stat View software was used for statistical analysis. Two-group comparisons were analyzed by the two-tailed *t*-test, and multiple comparisons were evaluated by ANOVA and Tukey or Dunnet tests, as appropriate. Values are presented as the mean of three technically independent experiments with a large number of biological samples (*n* = 282). *P* \< 0.05 is considered statistically significant.

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsomega.0c02850](https://pubs.acs.org/doi/10.1021/acsomega.0c02850?goto=supporting-info).Angiogenic analysis of vessel morphology; quantitative analysis of vessel morphology; total mesh area; raw data of extremities, nodes, and junctions; angiogenesis analysis; and representative analysis of cholesterol-added vessel morphology using Angiogenesis Analyzer ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02850/suppl_file/ao0c02850_si_001.pdf))
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